Jelena Grahovac has a PhD in Integrative Molecular Biology from the University of Pittsburgh School of Medicine. She completed postdoctoral training in tumor pathophysiology at the Massachusetts General Hospital /Harvard Medical School in the laboratory of Drs Rakesh Jain and Yves Boucher where she started studying pancreatic cancer. Dr Grahovac is currently a Research Associate Professor at the Institute for Oncology and Radiology of Serbia where she leads a small group studying novel therapeutic targets in PDAC.